Stewartsville, NJ, United States of America

Marc Poirier

USPTO Granted Patents = 19 (Patent Applications = 3)

CIPO Patents = 2

EPO Patents = 13 (Patent Applications = 10)

Average Co-Inventor Count = 7.2

ph-index = 2

Forward Citations = 55(Granted Patents)

Location History:

Parlin, NJ (US) (1998 - 1999)
Edison, NJ (US) (2002 - 2009)
Steartsville, NJ (US) (2009)
Stewartsville, NJ (US) (2009 - 2017)

Company Filing History:

Merck Sharp + Dohme Corp.

Years Active: 1998-2017

Loading Chart...

19 patents (USPTO):Sort by Forward Citations

Abstract keywords

1. 9822116 - Process and intermediates for the synthesis of 8-[{1-(3,5-bis-(trifluoromethyl)phenyl)-ethoxy}-methyl]-8-phenyl-1,7-diaza-spiro[4.5]decan-2-one compounds (2017-11-21),

2. 9688654 - Compounds inhibiting leucine-rich repeat kinase enzyme activity (2017-06-27),

3. 9440952 - Compounds inhibiting leucine-rich repeat kinase enzyme activity (2016-09-13),

4. 9416126 - Compounds inhibiting leucine-rich repeat kinase enzyme activity (2016-08-16),

5. 9249144 - Process and intermediates for the synthesis of 8-[{1-(3,5-bis-(trifluoromethyl)phenyl)-ethoxy}-methyl]-8-phenyl-1,7-diaza-spiro[4.5]decan-2-one compounds (2016-02-02),

6. 8680294 - Enantio- and stereo specific synthesis of β-amino-α-hydroxy amides (2014-03-25),

7. 8618314 - Exo- and diastereo-selective synthesis of himbacine analogs (2013-12-31),

8. 8258319 - Exo- and diastereo- selective synthesis of himbacine analogs (2012-09-04),

9. 7989653 - Exo- and diastereo-selective syntheses of himbacine analogs (2011-08-02),

10. 7605275 - Exo- and diastereo- selective syntheses of himbacine analogs (2009-10-20),

11. 7582763 - Enantioselective process (2009-09-01),

12. 7528263 - Oxidation process for the preparation of N-[3-amino-1-(cyclobutylmethyl)-2,3-dioxopropyl]-3-{N-[(tert-butylamino)carbonyl]-3-methyl-L-valyl}-6,6-dimethyl-3-azabicyclo[3.1.0]hexane-2-carboxamide and related compounds (2009-05-05),

13. 7049440 - Enantioselective process (2006-05-23),

14. 6750347 - Synthesis of intermediates useful in preparing tricyclic compounds (2004-06-15),

15. 6495689 - Synthesis of intermediates useful in preparing tricyclic compounds (2002-12-17),

Title: Innovations and Contributions of Marc Poirier in Pharmaceutical Patents

Introduction

Marc Poirier, based in Stewartsville, NJ, is a renowned inventor with a noteworthy record of 19 patents. His contributions primarily focus on the synthesis of compounds targeted for therapeutic uses, particularly in the pharmaceutical industry. Poirier has made significant advancements that may help in treating complex medical conditions.

Latest Patents

Among his latest inventions is a patent concerning a novel process for synthesizing 8-[{1-(3,5-bis-(trifluoromethyl)phenyl)-ethoxy}-methyl]-8-phenyl-1,7-diaza-spiro[4.5]decan-2-one compounds. This patent highlights a unique process that can be utilized in creating NK-1 inhibitor compounds for pharmaceutical applications. Additionally, it presents methods for preparing intermediates useful in this synthesis, along with procedures for removing metals from N-heterocyclic carbine metal complexes.

Another significant patent from Marc Poirier focuses on indazole compounds known to be effective inhibitors of LRRK2 kinase, which plays a crucial role in diseases such as Parkinson's Disease. This invention not only outlines the specific compounds but also discusses their pharmaceutical compositions and potential applications in both prevention and treatment of conditions linked to LRRK2 kinase.

Career Highlights

Throughout his career, Marc Poirier has held significant positions in reputable companies such as Schering Corporation and Merck Sharp & Dohme Corporation. His experiences in these organizations have likely contributed to his deep understanding of pharmaceutical innovations and the complexities involved in developing new medicinal compounds.

Collaborations

In his journey as an inventor, Marc has collaborated with notable individuals, including coworkers George G Wu and Frank Xing Chen. These collaborations have fostered an environment of innovation and have likely been instrumental in the successful development of his patented inventions.

Conclusion

Marc Poirier's contributions to the field of pharmaceuticals through his array of patents showcase his role as a pioneering inventor. His work, focused on the synthesis of critical compounds and inhibitors, emphasizes the profound impact that innovation can have on healthcare and treatment options. As he continues to develop new inventions, Poirier remains a key figure in the advancement of pharmaceutical science.

This text is generated by artificial intelligence and may not be accurate.